A literature review of cyclodextrin inclusion complexes characterization - Part III: Differential scanning calorimetry and thermogravimetry

International Journal of Pharmaceutical Sciences Review and Research

Volumn 12, Issue 1, 2012, Pages 16-20

  Takahashi, Andrea Ikeda ^a   Veiga, Francisco José Baptista ^b   Ferraz, Humberto Gomes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cyclodextrin; Differential scanning calorimetry; Thermogravimetry

Indexed keywords

CYCLODEXTRIN;

ACCURACY; ANALYTIC METHOD; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CRYSTALLIZATION; DEGRADATION KINETICS; DIFFERENTIAL SCANNING CALORIMETRY; ENCAPSULATION; INTERMETHOD COMPARISON; MELTING POINT; MOLECULAR INTERACTION; MOLECULAR MODEL; PHYSICAL CHEMISTRY; PREDICTION; REVIEW; THERMOGRAVIMETRY; TRANSITION TEMPERATURE; VALIDATION PROCESS;

EID: 84855499134     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Novák C, Ehen Z, Fodor M, Jicsinszky L, Orgovanyi J, Application of combined thermoanalytical techniques in the investigation of cyclodextrin inclusion complexes, J. Therm. Anal. Calorim., 84, 2006, 693-701.
2. Giordano F, Novak C, Moyano JR, Thermal analysis of cyclodextrin and their inclusion compounds, Thermochim. Acta, 380, 2001, 123-151.
3. Al-Marzouqi AH, Jobe B, Dowaidar A, Maestrelli F, Mura P, Evaluation of supercritical fluid technology as preparative technique of benzocaine - cyclodextrin complexes - Comparison with conventional methods, J. Pharm. Biomed. Anal., 43, 2007, 566-574.
4. Mura P, Zerrouk N, Faucci MT, Maestrelli F, Chemtob C, Comparative study of ibuproxamcomplexation with amorphous β- cyclodextrin derivatives is solution and in solid state, Eur. J. Pharm. Biopharm., 54, 2002, 181-191.
5. Li N, Zhang YH, Wu YN, Xiong XL, Zhang YH, Inclusion complex of trimethoprim with β-cyclodextrin, J. Pharm. Biomed. Anal., 39, 2005, 824-829.
6. Dahiya S, Pathak K, Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets, Pharmazie, 62, 2007, 278-283.
7. Bencini M, Ranucci E, Ferruti P, Trotta F, Donalisio M, Cornaglia M, Lembo D, Cavalli R, Preparation and in vitro evaluation of the antiviral activity of the acyclovir complex of a β-cyclodextrin/poly (amidoamine) copolymer, J. Controlled Release, 126, 2008, 17-25.
8. Garnero C, Longhi M, Study of ascorbic acid interaction with hydroxypropyl-β-cyclodextrin and triethanolamine, separately and in combination, J. Pharm. Biomed. Anal., 45, 2007, 536-545.
9. Jug M, Becirevic-Lacan M, Bengez S, Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol, Drug Dev. Ind. Pharm., 35, 2009, 796-807.
10. Berbicz F, Nogueira AC, Neto AM, Natali MRM, Baesso ML, Matioli G, Use of photoacoustic spectroscopy in the characterization of inclusion complexes of benzophenone-3-hydroxypropyl-β- cyclodextrin and ex vivo evaluation of the percutaneous penetration of sunscreen, Eur. J. Pharm. Biopharm., 79, 2011, 449-457.
11. Li N, Xu L, Thermal analysis of β-cyclodextrin/Berberine chloride inclusion compounds, ThermochimicaActa, 499, 2010, 166-170.
12. Jug M, Maestrelli F, Bragagni M, Mura P, Preparation and solidstate characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for bucal delivery, J. Pharm. Biom. Anal., 52, 2010, 9-18.
13. AlOmari AA, AlOmari MM, Badwan AA, Al-Sou'Od KA, Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state, J. Pharm. Biom. Anal., 54, 2011, 503-509.
14. Hirlekar R, Kadam V, Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem., 63, 2009, 219-224.
15. Capello B, DiMaio C, Iervolino M, Miro A, Combined effect of hydroxypropyl methylcellulose and hydroxypropyl-β-cyclodextrin on physicochemical and dissolution properties of celecoxib, J. Incl. Phenom. Macrocycl. Chem., 59, 2007, 237-244.
16. Nagarsenker MS, Joshi MS, Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage, Drug Dev. Ind. Pharm., 31, 2005, 169-178.
17. Castelli VVA, Trivieri G, Zucchelli I, Brambilla L, Barbuzzi T, Castiglioni C, Paci M, Zerbi G, Zanol M, Characterization of an inclusion complex between cladribine and 2-hydroxypropyl-β-cyclodextrin, J. Pharm. Sci., 97, 2008, 3897-3906.
18. AlOmari MM, El-Barghouthi MI, Zughul MB, Davies JED, Dipyridamole/β-cyclodextrincomplexation: Effect of buffer species, thermodynamics, and guest-host interactions probed by 1H-NMR and molecular modeling studies, J. Incl. Phenom. Macrocycl. Chem., 64, 2009, 305-315.
19. Sathigari S, Chadha G, Lee YHP, Wright N, Parsons DL, Rangari VK, Fasina O, Babu RJ, Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes, AAPS Pharm. Sci. Tech., 10, 2009, 81-87.
20. Cappello B, Di Maio C, Iervolino M, Miro A, Calignano A, Etodolac/cyclodextrin formulations: Physicochemical characterization and in vivo pharmacological studies, Drug Dev. Ind. Pharm., 35, 2009, 877-886.
21. AlOmari MM, Badwan AA, Zughul MB, Davies JED, Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical and computational analisys, Drug Dev. Ind. Pharm., 33, 2007, 1205-1215.
22. Asbahr ACC, Franco L, Barison A, Silva CWP, Ferraz HG, Rodrigues LNC, Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization, Bioorg. Med. Chem., 17, 2009, 2718-2723.
23. Kim JK, Kim MS, Park JS, Kim CK, Thermo-reversible flurbiprofen liquid suppository with HP-β-CD as a solubility enhancer: improvement of rectal bioavailability, J. Incl. Phenom. Macrocycl. Chem., 64, 2009, 265-272.
24. Cirri M, Righi MF, Maestrelli F, Mura P, Valleri M, Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers, Drug Dev. Ind. Pharm., 35, 2009, 73-82.
25. Cho HJ, Balakrishnan P, Shim WS, Chung SJ, Shim CK, Kim DD, Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery, Int. J. Pharm., 2010, 400, 59-65.
26. Hirlekar R, Kadam V, Preformulation Study of the Inclusion Complex Irbesartan-β-Cyclodextrin, AAPS Pharm. Sci. Tech., 10, 2009, 276-281.
27. Lee SY, Jung II, Kim JK, Lim GB, Ryu JH, Preparation of itraconazole/HP-β-CD inclusion complexes using supercritical aerosol solvent extraction system and their dissolution characteristics, J. Supercrit. Fluids., 44, 2008, 400-408.
28. Al-Marzouqi AH, Elwy HM, Shehadi I, Adem A, Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques, J. Pharm. Biomed. Anal., 49, 2009, 227-233.
29. Omar L, El-Barghouthi MI, Masoud NA, Abdoh AA, Al-Omari MM, Zughul MB, Badwan AA, Inclusion complexation of loratadine with natural and modified cyclodextrins:phase solubility and thermodynamic studies, J. Solution Chem., 36, 2007, 605-616.
30. Nacsa A, Ambrus R, Berkesi O, Szabó-Révéz P, Aigner Z, Watersoluble loratadine inclusion complex: Analytical control of the preparation by microwave irradiation, J. Pharm. Biomed. Anal., 48, 2008, 1020-1023.
31. Nacsa A, Berkesi O, Szabó-Révész P, Aigner Z, Achievement of pHindependence of poorly-soluble, ionizableloratadine by inclusion complex formation with dimethyl-b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem., 64, 2009, 249-254.
32. Jug M, Becirevic-Lacan M, Development of a cyclodextrin-based nasal delivery system for lorazepam, Drug Dev. Ind. Pharm., 34, 2008, 817-826.
33. Obaidat AA, Khanfar RA, Khawam MN, The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling, J. Incl. Phenom. Macrocycl. Chem., 63, 2009, 273-279.
34. Wang J, Cai Z, Investigation of inclusion complex of miconazole nitrate with β- cyclodextrin, Carbohydr. Polym., 72, 2008, 255-260.
35. Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L, Solid-state characterization and dissolution properties of Naproxen-Arginine-Hydroxypropyl-β-cyclodextrin ternary system, Eur. J. Pharm. Biopharm., 59, 2005, 99-106.
36. Yan Z, Xu W, Sun J, Liu X, Zhao Y, Sun Y, Zhang T, He Z, Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-β-cyclodextrin, Drug Dev. Ind. Pharm., 34, 2008, 632-641.
37. Maestrelli F, Cecchi M, Cirri M, Capasso G, Mennini N, Mura P, Comparative study of oxaprozincomplexation with natural and chemically-modified cyclodextrins in solution and in the solid state, J. Incl. Phenom. Macrocycl., 63, 2009, 17-25.
38. Bilensoy E, Gürkaynak O, Ertan M, Sen M, Hincal AA, Development of nanoparticles loaded with anticancer drug paclitaxel, J. Pharm. Sci., 97, 2008, 1519-1529.
39. Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W, Piroxicam/2- Hydroxypropyl-β-Cyclodextrin Inclusion Complex Prepared by a New Fluid-Bed Coating Technique, J. Pharm. Sci., 98, 2009, 665-675.
40. Banchero M, Manna L, Investigation of the piroxicam/hydroxypropyl-β-cyclodextrin inclusion complexation by means of a supercritical solvent in the presence of auxiliary agents, J. Supercrit. Fluid., 57, 2011, 259-266.
41. Ghuzlaan A, AlOmari MM, Al-Sou'Od KA, Prednisone/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical and computational analysis, J. Solution Chem., 38, 2009, 83-94.
42. Araujo MVG, Macedo OFL, Nascimento CC, Conegero LS, Barreto LS, Almeida LE, Costa-Jr NB, Gimenez IF,Characterization, phase solubility and molecular modeling of α- cyclodextrin/pyrimethamine inclusion complex, Spectrochim. Acta, Part A, 72, 2009, 165-170.
43. AlOmari MM, Zughul MB, Davies JED, Badwan AA, Sildenafil/cyclodextrincomplexation: Stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies, J. Pharm. Biomed. Anal., 41, 2006, 857-865.
44. Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, LaRotonda MI, Use of cyclodextrins as solubilizing agentes for simvastatin: Effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium, Int. J. Pharm., 404, 2011, 49-56.
45. Rajabi O, Tayyari F, Salari R, Tayyari SF, Study of interaction of spironolactone with hydroxypropyl-β-cyclodextrin in aqueous solution and in solid state, J. Mol. Struct., 878, 2008, 78-83.
46. Jug M, Kosalec I, Maestrelli F, Mura P, Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative, J. Pharm. Biom. Anal., 54, 2011, 1030-1039.
47. Doiphode D, Gaikwad S, Pore Y, Kuchekar B, Late S, Effect of β- cyclodextrincomplexation on physicochemical properties of zaleplon, J. Incl. Phenom. Macrocycl. Chem., 62, 2008, 43-50.
48. Eid EEM, Abdul AB, Suliman FEO, Sukari MA, Rasedee A, Fatah SS, Characterization of the inclusion complex of zerumbone with hydroxypropyl-β-cyclodextrin, Carbohydrate Polymers, 83, 2011, 1707-1714.
49. Trotta F, Zanetti M, Camino G, Thermal degradation of cyclodextrins, Polym. Degrad. Stab., 69, 2000, 373-379.
50. Araújo MVG, Vieira EKB, Lázaro GS, Conegero LS, Ferreira OP, Almeida LE, Barreto LS, Costa-Jr NB, Gimenez IF, Inclusion complexes of pyrimethamine in 2-hydroxypropyl-β-cyclodextrin: Characterization, phase solubility and molecular modeling, Bioorg. Med. Chem., 15, 2007, 5752-5759.
51. Ammar HO, Salama HA, Ghorab M, Mahmoud AA, Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems, Int. J. Pharm., 309, 2006, 129-138.
52. Yuan C, Jin Z, Xu X, Zhuang H, Shen W, Preparation and stability of the inclusion complex of astaxanthin with hydroxypropyl-β- cyclodextrin, Food Chem., 109, 2008, 264-268.
53. Dias K, Nikolau S, De Giovani WF, Synthesis and spectral investigation of Al(III) catechin/β-cyclodextrin and Al(III) quercetin/β-cyclodextrin inclusion compounds, Spectrochim. Acta, Part A, 70, 2008, 154-161.
54. Marreto RN, Almeida EECV, Alves PB, Niculau ES, Nunes RS, Matos CRS, Araújo AAS, Thermal analysis and gas chromatography coupled mass spectrometry analyses of hydroxypropyl-β- cyclodextrin inclusion complex containing Lippiagracilis essential oil, Thermochim. Acta, 475, 2008, 53-58.
55. Song LX, Guo XQ, Du FY, Bai L, Thermal degradation comparison of polypropylene glycol and its complex with β-cyclodextrin, Polym. Degrad. Stabil., 95, 2010, 508-515.